Skip to main content

Table 3 Experience of torture methods, pain complaints and emotional disturbances reported by the victims, n = 125

From: Survivors of war in the Northern Kosovo (II): baseline clinical and functional assessment and lasting effects on the health of a vulnerable population

Number of torture methods experienced

Male (n)

Female (n)

Total (%)

Difference between male and female by Kolmogorov-Smirnov test

corrected P value

0

8

14

22 (17.6)

P < 0.001

1

8

18

26 (20.8)

 

2

9

14

23 (18.4)

 

3

13

2

15 (12.0)

 

4

3

3

6 (4.8)

 

≥ 5

22

11

33 (26.4)

 

Pain severity within two weeks

Male (n)

Female (n)

Total (%)

 

No pain

3

4

7 (5.8)

P = 0.925

Light pain

12

17

29 (24.2)

 

Moderate pain

28

18

46 (38.3)

 

Severe pain

17

21

38 (31.7)

 

Pain frequency within two weeks

Male (n)

Female (n)

Total (%)

 

Constant pain (all the time)

26

23

49 (45.4)

P = 1

Periodic pain (one or more times a week)

24

26

50 (46.3)

 

Occasional pain (less than once a week)

5

4

9 (8.3)

 

Emotional disturbance within two weeks

Male (n)

Female (n)

Total (%)

 

Anger

60

54

114 (91.2)

P = 0.977

Aggressiveness

45

36

81 (64.8)

P = 0.558

Crying

35

53

88 (70.4)

P < 0.005

Family non-cooperative

41

41

82 (65.6)

P = 1

A feeling of being insulted

24

35

59 (47.2)

P = 0.187

Hatred

33

43

76 (60.8)

P = 0.263

Helplessness

42

47

89 (71.2)

P = 0.936

Inferiority complex

39

42

81 (64.8)

P = 1

Loss of interest

42

42

84 (67.2)

P = 1

Memory loss

44

46

90 (72.0)

P = 1

Police or military phobia

44

42

86 (68.8)

P = 1

Sadness

27

46

73 (58.4)

P < 0.005

Sexual dysfunction

37

31

68 (54.4)

P = 0.956

Sleep disorder

49

51

100 (80.0)

P = 1

Social isolation

43

41

84 (67.2)

P = 1

Hopelessness

43

42

85 (68.0)

P = 1

Number of emotional disturbances

Male (n)

Female (n)

Total (%)

 

0

3

2

5 (4.0)

P = 0.951

1 to 3

6

2

8 (6.4)

 

4 to 7

5

6

11 (8.8)

 

8 to 11

16

16

32 (25.6)

 

≥12

33

36

69 (55.2)

Â